DCTH Delcath Systems, Inc. - Common Stock
$16,99
Harga · Agu 20, 2026
Fundamental per Agu 6, 2026
Rentang 52M
$8–$17
95% of range
Peringkat Analis
BUY
12 analysts
Target Harga
$24
+41% upside
P/E (TTM)
242.7
ROE
2.5%
Margin Laba Bersih
3.2%
Tentang Delcath Systems, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Delcath Systems, Inc. is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally.
Baca selengkapnya
Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company, that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally (e.g. specialty drugs, melphalan (trade name Alkeran), busulfan, capecitabine).
## Phase III melanoma trial enrolling
University of Pittsburgh Medical Center
National Cancer Institute in Bethesda, Maryland
Albany Medical Center in Albany, New York
John Wayne Cancer Center in Santa Monica, California
Moffitt Cancer Center in Tampa, Florida
Morristown Memorial Hospital in Morristown, New Jersey
Providence Cancer Center in Portland, Oregon
St. Luke's Cancer Center of Bethlehem, Pennsylvania
Swedish Medical Center in Englewood, Colorado
University of Maryland Medical Center in Baltimore, Maryland
University of Texas Medical Branch in Galveston, Texas
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
DCTH Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$16.99
Kapitalisasi Pasar
$589M
P/E (TTM)
242.7
EPS (TTM)
$0.07
Pendapatan (TTM)
$85M
Imbal Hasil Dividen
—
ROE
2.5%
D/E Utang/Ekuitas
—
Rentang 52M
$8 – $17
DCTH Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$85M
2016-12-31
→
2025-12-31
EPS
$0.07
2017-12-31
→
2025-12-31
Arus Kas Bebas
$21M
2018-12-31
→
2025-12-31
Margin
3.2%
2022-12-31
→
2025-12-31
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
DCTH
Median Rekan
P/E (TTM)
242.7
32.9
P/S (TTM)
6.9
4.6
P/B
5.3
3.5
Price / FCF (Harga / FCF)
28.1
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
DCTH
Median Rekan
Gross Margin (Margin Kotor)
86.2%
66.5%
Operating Margin (Margin Operasi)
0.77%
—
Net Profit Margin (Margin Laba Bersih)
3.2%
-9.8%
ROA
2.7%
-8.8%
ROE
2.5%
-15.5%
ROIC
0.46%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
DCTH
Median Rekan
Current Ratio (Rasio Lancar)
10.9
4.8
Quick Ratio (Rasio Cepat)
5.0
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
DCTH
Median Rekan
Revenue YoY (Pendapatan YoY)
129.1%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
215.3%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
DCTH
Median Rekan
DCTH Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
12 analis
- Beli Kuat 3 25,0%
- Beli 8 66,7%
- Tahan 1 8,3%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
5 analis · 2026-08-18
Median
$22.00
Rata-rata
$24.00
← Di bawah semua target
$16.99
Rendah
$21.00
Tinggi
$32.00
Target median
$22.00
+29,5%
Target rata-rata
$24.00
+41,3%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.05%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $0.07 | $-0.09 | 0.16% |
| 31 Maret 2026 | $-0.03 | $-0.09 | 0.06% |
| 31 Des. 2025 | $-0.05 | $-0.06 | 0.01% |
| 30 Sep. 2025 | $0.02 | $0.02 | -0.00% |
| 30 Juni 2025 | $0.07 | $0.03 | 0.04% |
| 31 Maret 2025 | $0.03 | $0.02 | 0.01% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| DCTH | $350M | 144.3 | 129.1% | 3.2% | 2.5% | 86.2% |
| SIBN | $861M | -44.8 | 20.2% | -9.4% | -10.9% | 79.6% |
| SSII | — | -94.7 | 105.7% | — | — | — |
| ANGO | $479M | -13.0 | 9.5% | -11.5% | -21.2% | 54.6% |
| TCMD | $651M | 35.4 | 12.5% | 5.8% | 9.2% | 75.9% |
| NPCE | $518M | -23.4 | 25.1% | -21.5% | -111.6% | 77.2% |
| CLPT | $402M | -15.2 | 17.8% | -69.1% | -106.9% | 61.4% |
| SGHT | $424M | -10.7 | -3.1% | -49.7% | -57.4% | 86.2% |
| SENS | $228M | -3.3 | 56.9% | -196.0% | -88.7% | 44.7% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 18
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $85M | $37M | $2M | $3M | $4M | · | · | · | $3M | $2M | $2M | $1M | |
| Cost of Revenue | $12M | $6M | $635.0K | $686.0K | $671.0K | $640.0K | $719.0K | $1M | $701.0K | $550.0K | $462.0K | $291.0K | |
| Gross Profit | $73M | $31M | $1M | $2M | $3M | $1M | $861.0K | $2M | $2M | $1M | $1M | $778.0K | |
| R&D Expense | $29M | $14M | $18M | $19M | $14M | $11M | $9M | $20M | $10M | $8M | $6M | $4M | |
| SG&A Expense | $44M | $30M | $22M | $17M | $14M | $11M | $11M | $10M | $10M | $9M | $10M | $16M | |
| Operating Expenses | $73M | $43M | $40M | $36M | $27M | $22M | $21M | $29M | $20M | $18M | $16M | $20M | |
| Operating Income | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | $-18M | $-16M | $-15M | $-19M | |
| Interest Expense | · | · | · | · | · | · | · | · | $22M | $14M | $67.0K | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | $17.0K | $9.0K | $5.0K | |
| Other Non-op | $-70.0K | $-30.0K | $-59.0K | $30.0K | $68.0K | $154.0K | $2.0K | $51.0K | $-41.0K | $17.0K | $9.0K | $-24.0K | |
| Pretax Income | $4M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Income Tax | $810.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| EPS (Basic) | $0.08 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| EPS (Diluted) | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 | $-8.35 | $-342.83 | $-0.72 | $-3250.00 | · | $-0.91 | $-1.84 | |
| Shares (Basic) | 35,821,157 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| Shares (Diluted) | 39,919,557 | 28,511,393 | 16,229,931 | 8,864,615 | 7,145,754 | 2,897,827 | 25,900 | 26,705,375 | 14,039 | · | 16,161,687 | 9,452,050 | |
| EBITDA | $660.0K | $-12M | $-38M | $-34M | $-25M | $-21M | $-20M | $-27M | · | · | $-15M | $-19M |
Neraca 25
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $32M | $13M | $8M | $23M | $29M | $10M | $3M | $4M | $4M | $13M | $20M | |
| Receivables | $12M | $11M | $241.0K | $366.0K | $44.0K | $57.0K | $21.0K | $585.0K | $317.0K | $403.0K | $277.0K | $174.0K | |
| Inventory | $10M | $7M | $3M | $2M | $1M | $855.0K | $654.0K | $858.0K | $1M | $660.0K | $757.0K | $349.0K | |
| Prepaid Expense | $6M | $3M | $1M | $2M | $3M | $3M | $2M | $898.0K | $700.0K | $698.0K | $960.0K | $974.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $222.0K | |
| Current Assets | $120M | $74M | $37M | $16M | $31M | $32M | $13M | $6M | $8M | $34M | $15M | $22M | |
| PP&E (Net) | $3M | $2M | $1M | $1M | $1M | $1M | $735.0K | $925.0K | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | |
| Total Assets | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Accounts Payable | $3M | $961.0K | $1M | $2M | $638.0K | $2M | $5M | $8M | $4M | $594.0K | $284.0K | $748.0K | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $5M | $7M | $8M | $3M | $3M | $2M | $4M | |
| Current Liabilities | $11M | $6M | $16M | $15M | $6M | $10M | $16M | $18M | $8M | $36M | $6M | $5M | |
| Capital Leases | $835.0K | $933.0K | $0 | · | $207.0K | $450.0K | $197.0K | $0 | · | · | · | · | |
| Other Non-current Liabilities | $628.0K | $766.0K | $840.0K | $1M | $207.0K | · | $0 | $628.0K | $395.0K | $604.0K | $820.0K | $1M | |
| Total Liabilities | $12M | $8M | $23M | $24M | $21M | $13M | $21M | $22M | $8M | $37M | $7M | $6M | |
| Long-term Debt | · | $0 | $10M | $16M | · | · | · | · | · | · | · | · | |
| Common Stock | $347.0K | $331.0K | $228.0K | $100.0K | $79.0K | $60.0K | $1.0K | $0 | $2.0K | $0 | $14.0K | $97.0K | |
| Paid-in Capital | $639M | $600M | $521M | $452M | $433M | $417M | $365M | $329M | $326M | $278M | $270M | $265M | |
| Retained Earnings | $-529M | $-532M | $-505M | $-457M | $-421M | $-395M | $-371M | $-344M | $-325M | $-279M | $-261M | $-247M | |
| Treasury Stock | · | · | · | · | · | · | · | $0 | $51.0K | $51.0K | $51.0K | $51.0K | |
| AOCI | $575.0K | $82.0K | $135.0K | $-83.0K | $18.0K | $-104.0K | $28.0K | $50.0K | $42.0K | $-41.0K | $-8.0K | $20.0K | |
| Stockholders' Equity | $111M | $69M | $16M | $-6M | $12M | $22M | $-6M | $-15M | $678.0K | $-1M | $9M | $18M | |
| Liabilities + Equity | $124M | $77M | $39M | $18M | $33M | $35M | $14M | $7M | $9M | $35M | $16M | $24M | |
| Shares Outstanding | 34,691,671 | 33,061,002 | 22,761,554 | 10,046,571 | 7,906,728 | 5,996,101 | 67,091 | 14,715 | 228,139 | 11,750 | 1,360,239 | 9,708,841 |
Arus Kas 12
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $23M | $-19M | $-31M | $-25M | $-23M | $-23M | $-24M | $-15M | $-15M | $-14M | $-16M | $-16M | |
| CapEx | $2M | $559.0K | $58.0K | $209.0K | $143.0K | $782.0K | $24.0K | $76.0K | $524.0K | $258.0K | $170.0K | $44.0K | |
| Investing Cash Flow | $-27M | $-981.0K | $-20M | $-209.0K | $-143.0K | $-782.0K | $-24.0K | $-76.0K | $-524.0K | · | · | · | |
| Net Debt Issued | · | $-11M | $-6M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $481.0K | $250.0K | $123.0K | $0 | $2M | $230.0K | $0 | $11M | · | · | · | · | |
| Stock Repurchased | $6M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-6M | $250.0K | $123.0K | · | $2M | $230.0K | $0 | · | · | · | · | · | |
| Financing Cash Flow | $15M | $39M | $52M | $10M | $21M | $42M | $30M | $13M | $-11M | · | · | · | |
| Net Change in Cash | $11M | $20M | $874.0K | $-15M | $-2M | $19M | $7M | $-2M | $-26M | $-8M | $-8M | $-11M | |
| Taxes Paid | $2M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $21M | $-19M | $-31M | $-25M | $-23M | $-24M | $-24M | $-15M | · | · | $-17M | $-16M |
Profitabilitas 8
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.2% | 83.4% | 69.2% | 74.8% | · | · | · | · | · | · | 73.6% | 72.8% | |
| Operating Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| Net Margin | 3.2% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | -1625.9% | |
| Pretax Margin | 4.1% | -70.9% | -2308.9% | -1342.7% | · | · | · | · | · | · | -841.7% | · | |
| EBITDA Margin | 0.77% | -33.4% | -1849.0% | -1245.0% | · | · | · | · | · | · | -870.6% | -1805.8% | |
| ROA | 2.7% | -45.8% | -168.8% | -143.2% | -75.7% | -98.9% | -84.3% | -244.4% | · | · | -74.5% | -57.1% | |
| ROE | 2.5% | -68.2% | -235.5% | 657.5% | -216.7% | -190.6% | 70.5% | 194.1% | · | · | -109.9% | -72.0% | |
| ROIC | 0.46% | -18.1% | -242.0% | 577.8% | -205.3% | -96.5% | 313.2% | · | · | · | -176.8% | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 | 3.2 | 0.8 | 0.3 | · | · | 2.3 | 4.8 | |
| Quick Ratio | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 | 2.9 | 0.6 | 0.2 | · | · | 2.0 | 4.5 |
Efisiensi 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.6 | 0.1 | 0.1 | · | · | · | · | · | · | 0.1 | 0.0 | |
| Inventory Turnover | 1.4 | 1.2 | 0.2 | 0.4 | 0.6 | 0.8 | 1.0 | 1.0 | · | · | 0.8 | 0.5 | |
| Receivables Turnover | 7.5 | 6.7 | 6.8 | 13.3 | · | · | · | · | · | · | 7.7 | 4.1 |
Tingkat Pertumbuhan 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 129.1% | 1701.7% | -24.1% | -23.5% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 215.3% | 118.7% | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $85M | $37M | $2M | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Net Income TTM | $3M | $-26M | $-48M | $-37M | $-26M | $-24M | $-9M | $-19M | $-45M | $-18M | $-15M | $-17M | |
| Market Cap | $350M | $398M | $95M | $28M | $61M | $107M | $1M | $2.01B | · | · | · | · | |
| P/E | 144.3 | -12.9 | -1.4 | -0.9 | -2.2 | -2.1 | -0.1 | -272.2 | · | · | · | · | |
| P/S | 4.1 | 10.7 | 45.9 | 10.5 | 17.2 | 34.8 | 0.5 | 649.3 | · | · | · | · | |
| P/B | 3.2 | 5.8 | 6.0 | -4.9 | 5.1 | 4.9 | -0.2 | -134.2 | · | · | · | · | |
| P / Tangible Book | 3.2 | 5.8 | 6.0 | · | 5.1 | 4.9 | · | · | · | · | · | · | |
| P / Cash Flow | 15.6 | -21.3 | -3.0 | -1.1 | -2.7 | -4.7 | -0.1 | -136.1 | · | · | · | · | |
| P / FCF | 16.7 | -20.7 | -3.0 | -1.1 | -2.7 | -4.5 | -0.1 | -135.4 | · | · | · | · | |
| Earnings Yield | 0.69% | -7.7% | -70.7% | -114.4% | -46.3% | -46.6% | -1613.3% | -0.37% | · | · | · | · |
Laporan Laba Rugi 16
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $25M | $21M | $21M | $24M | $20M | $15M | $11M | $8M | $3M | $539.0K | $434.0K | $495.0K | $597.0K | $638.0K | $906.0K | |
| Cost of Revenue | $3M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $903.0K | $171.0K | $133.0K | $150.0K | $181.0K | $238.0K | $235.0K | |
| Gross Profit | $26M | $21M | $18M | $18M | $21M | $17M | $13M | $10M | $6M | $2M | $368.0K | $301.0K | $345.0K | $416.0K | $400.0K | $671.0K | |
| R&D Expense | $10M | $10M | $9M | $8M | $7M | $5M | $3M | $4M | $3M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | |
| SG&A Expense | $13M | $13M | $11M | $10M | $11M | $11M | $7M | $7M | $7M | $9M | $7M | $6M | $5M | $4M | $4M | $5M | |
| Operating Expenses | $24M | $23M | $20M | $18M | $18M | $16M | $10M | $11M | $10M | $13M | $12M | $11M | $8M | $9M | $8M | $9M | |
| Operating Income | $2M | $-2M | $-2M | $-388.0K | $3M | $642.0K | $3M | $-1M | $-4M | $-10M | $-11M | $-11M | $-8M | $-8M | $-8M | $-8M | |
| Other Non-op | $-17.0K | $-58.0K | $-7.0K | $-33.0K | $-34.0K | $4.0K | $-53.0K | $35.0K | $10.0K | $-22.0K | $-73.0K | $-5.0K | $6.0K | $13.0K | $27.0K | $26.0K | |
| Pretax Income | $3M | $-908.0K | $-1M | $375.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | · | · | · | · | · | · | |
| Income Tax | $491.0K | $162.0K | $562.0K | $-455.0K | $508.0K | $195.0K | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $3M | $-1M | $-2M | $830.0K | $3M | $1M | $-3M | $2M | $-14M | $-11M | $-11M | $-20M | $-7M | $-9M | $-8M | $-9M | |
| EPS (Basic) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.08 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| EPS (Diluted) | $0.07 | $-0.03 | $-0.05 | $0.02 | $0.07 | $0.03 | $-0.06 | $0.06 | $-0.48 | $-0.45 | $-0.45 | $-1.14 | $-0.58 | $-0.77 | $-0.82 | $-0.96 | |
| Shares (Basic) | 35,891,915 | 36,021,210 | -70,991,574 | 36,383,277 | 35,786,813 | 34,642,641 | -53,478,825 | 28,738,307 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| Shares (Diluted) | 39,761,480 | 36,021,210 | -79,911,141 | 40,056,814 | 40,262,764 | 39,511,120 | -57,086,190 | 32,345,672 | 28,364,731 | 24,887,180 | -25,719,196 | 17,863,078 | 12,463,665 | 11,622,384 | -16,732,137 | 9,215,786 | |
| EBITDA | $2M | $-2M | · | $-388.0K | $3M | $642.0K | · | $-1M | $-4M | $-10M | · | $-11M | $-8M | $-8M | · | $-8M |
Neraca 23
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $48M | $41M | $43M | $42M | $34M | $13M | $32M | $8M | $15M | $12M | $13M | $40M | $15M | $24M | $8M | $10M | |
| Receivables | $16M | $14M | $12M | $14M | $16M | $14M | $11M | $7M | $4M | $2M | $241.0K | $205.0K | $127.0K | $458.0K | $366.0K | $537.0K | |
| Inventory | $12M | $10M | $10M | $11M | $11M | $7M | $7M | $7M | $6M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $7M | $7M | $6M | $7M | $6M | $4M | $3M | $1M | $1M | $1M | $1M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $131M | $120M | $120M | $121M | $113M | $84M | $74M | $29M | $31M | $34M | $37M | $46M | $19M | $29M | $16M | $18M | |
| PP&E (Net) | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Assets | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Accounts Payable | $4M | $3M | $3M | $2M | $5M | $2M | $961.0K | $937.0K | $3M | $1M | $1M | $753.0K | $966.0K | $2M | $2M | $3M | |
| Accrued Liabilities | $9M | $7M | $8M | $6M | $6M | $4M | $5M | $6M | $4M | $4M | $5M | $5M | $6M | $7M | $5M | $5M | |
| Current Liabilities | $13M | $11M | $11M | $8M | $10M | $5M | $6M | $22M | $12M | $13M | $16M | $14M | $11M | $13M | $15M | $14M | |
| Capital Leases | $2M | $815.0K | $835.0K | $855.0K | $877.0K | $906.0K | $933.0K | $963.0K | $989.0K | $1M | $0 | · | · | · | · | · | |
| Other Non-current Liabilities | $327.0K | $615.0K | $628.0K | $582.0K | $578.0K | $896.0K | $766.0K | $563.0K | $632.0K | $962.0K | $840.0K | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $16M | $12M | $12M | $9M | $12M | $7M | $8M | $23M | $30M | $21M | $23M | $23M | $21M | $25M | $24M | $25M | |
| Long-term Debt | · | · | · | · | · | · | · | $2M | $4M | $7M | $10M | · | · | · | $16M | · | |
| Common Stock | $346.0K | $344.0K | $347.0K | $353.0K | $350.0K | $334.0K | $331.0K | $280.0K | $279.0K | $254.0K | $228.0K | $197.0K | $153.0K | $101.0K | $100.0K | $86.0K | |
| Paid-in Capital | $648M | $642M | $639M | $641M | $632M | $610M | $600M | $536M | $534M | $530M | $521M | $519M | $473M | $453M | $452M | $442M | |
| Retained Earnings | $-527M | $-530M | $-529M | $-527M | $-528M | $-530M | $-532M | $-528M | $-530M | $-516M | $-505M | $-494M | $-474M | $-466M | $-457M | $-447M | |
| AOCI | $258.0K | $571.0K | $575.0K | $875.0K | $592.0K | $381.0K | $82.0K | $11.0K | $8.0K | $157.0K | $135.0K | $-59.0K | $-64.0K | $-64.0K | $-83.0K | $-57.0K | |
| Stockholders' Equity | $121M | $113M | $111M | $115M | $105M | $80M | $69M | $9M | $4M | $15M | $16M | $25M | $-242.0K | $-13M | $-6M | $-5M | |
| Liabilities + Equity | $137M | $125M | $124M | $124M | $117M | $87M | $77M | $32M | $34M | $36M | $39M | $48M | $21M | $31M | $18M | $20M | |
| Shares Outstanding | 34,636,252 | 34,465,087 | 34,691,671 | 35,308,939 | 34,955,974 | 33,436,612 | 33,061,002 | 28,019,599 | 27,931,393 | 25,439,319 | 22,761,554 | 19,688,991 | 15,250,469 | 10,046,571 | 10,046,571 | 8,597,682 |
Arus Kas 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6M | $857.0K | $8M | $5M | $7M | $2M | $-1M | $-4M | $-4M | $-10M | $-8M | $-9M | $-10M | $-4M | $-7M | $-5M | |
| CapEx | $503.0K | $570.0K | $550.0K | $459.0K | $398.0K | $140.0K | $229.0K | $216.0K | $101.0K | $13.0K | $19.0K | $-1.0K | $40.0K | $0 | $0 | $68.0K | |
| Investing Cash Flow | $-504.0K | $-571.0K | $-561.0K | $-466.0K | $-415.0K | $-25M | $-15M | $-697.0K | $10M | $5M | $-20M | $1.0K | $-40.0K | $0 | $0 | $-68.0K | |
| Stock Issued | $0 | $389.0K | $0 | $243.0K | $0 | $238.0K | $0 | $175.0K | $0 | $75.0K | $0 | $76.0K | $0 | $47.0K | $0 | $0 | |
| Stock Repurchased | $11.0K | $3M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-3M | · | · | · | $238.0K | · | · | · | $75.0K | · | · | · | $47.0K | · | · | |
| Financing Cash Flow | $962.0K | $-2M | $-6M | $3M | $15M | $3M | $40M | $-2M | $-3M | $4M | $1.0K | $35M | $7.0K | $17M | $5M | $5M | |
| Net Change in Cash | $6M | $-2M | $2M | $7M | $22M | $-20M | $24M | $-6M | $3M | $-886.0K | $-28M | $26M | $-10M | $12M | $-2M | $-372.0K | |
| Taxes Paid | · | · | $228.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $287.0K | · | · | · | $2M | · | · | · | $-10M | · | · | · | $-4M | · | · |
Profitabilitas 8
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.8% | 85.0% | · | 87.2% | 86.3% | 85.6% | · | 85.4% | 80.4% | 71.2% | · | 69.3% | 69.7% | 69.7% | · | · | |
| Operating Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| Net Margin | 9.2% | -4.3% | · | 4.0% | 11.2% | 5.4% | · | 16.6% | -176.9% | -354.0% | · | -4686.6% | -1455.0% | -1507.5% | · | · | |
| Pretax Margin | 10.8% | -3.6% | · | 1.8% | 13.3% | 6.4% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 8.2% | -6.6% | · | -1.9% | 10.7% | 3.2% | · | -11.2% | -50.4% | -327.4% | · | -2432.3% | -1615.6% | -1394.5% | · | · | |
| ROA | 2.1% | -1.0% | · | 1.1% | 3.6% | 1.7% | · | 4.7% | -50.0% | -33.3% | · | -60.0% | -34.2% | -31.1% | · | -31.1% | |
| ROE | 2.4% | -1.1% | · | 1.4% | 4.9% | 2.2% | · | 11.2% | -695.8% | -1439.2% | · | -208.9% | 466.5% | 229.3% | · | -262.5% | |
| ROIC | 1.7% | -1.7% | · | -0.75% | 2.1% | 0.68% | · | · | · | · | · | · | · | · | · | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.8 | 11.2 | · | 15.1 | 10.9 | 16.0 | · | 1.3 | 2.6 | 2.5 | · | 3.3 | 1.8 | 2.2 | · | 1.3 | |
| Quick Ratio | 4.8 | 5.2 | · | 6.9 | 4.8 | 5.1 | · | 0.7 | 1.5 | 1.0 | · | 2.9 | 1.3 | 1.8 | · | 0.7 |
Efisiensi 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.5 | · | 0.4 | 0.3 | 0.3 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.8 | 1.8 | · | 2.0 | 2.5 | 2.6 | · | 3.1 | 4.0 | 3.1 | · | 1.2 | 1.8 | 1.9 | · | · |
Valuasi (TTM) 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $99M | $89M | · | $76M | $63M | $42M | · | $23M | $12M | $5M | · | $2M | $3M | $3M | · | · | |
| Net Income TTM | $5M | $4M | · | $6M | $-8M | $-22M | · | $-43M | $-52M | $-48M | · | $-45M | $-35M | $-37M | · | $-35M | |
| Market Cap | $436M | $320M | · | $380M | $475M | $426M | · | $253M | $234M | $121M | · | $80M | $89M | $58M | · | $28M | |
| P/E | 96.8 | 103.1 | · | 59.7 | -42.5 | -15.2 | · | -4.5 | -3.2 | -1.6 | · | -1.2 | -1.6 | -1.4 | · | -0.8 | |
| P/S | 4.4 | 3.6 | · | 5.0 | 7.6 | 10.2 | · | 11.2 | 19.8 | 26.0 | · | 32.8 | 31.8 | 21.6 | · | · | |
| P/B | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | -367.4 | -4.4 | · | -5.2 | |
| P / Tangible Book | 3.6 | 2.8 | · | 3.3 | 4.5 | 5.3 | · | 29.5 | 55.8 | 8.3 | · | 3.2 | · | · | · | · | |
| P / Cash Flow | · | 373.2 | · | · | · | 193.2 | · | · | · | -12.7 | · | · | · | -13.5 | · | · | |
| P / FCF | · | 1114.4 | · | · | · | 206.3 | · | · | · | -12.6 | · | · | · | -13.5 | · | · | |
| Earnings Yield | 1.0% | 0.97% | · | 1.7% | -2.4% | -6.6% | · | -22.3% | -31.7% | -61.6% | · | -85.2% | -60.9% | -70.8% | · | -132.5% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $85M | $37M | $2M | $3M | $4M |
| Margin Kotor % | 86.2% | 83.4% | 69.2% | 74.8% | — |
| Margin Operasi % | 0.77% | -33.4% | -1849.0% | -1245.0% | — |
| Laba Bersih | $3M | $-26M | $-48M | $-37M | $-26M |
| EPS Dilusian | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 10.9 | 12.0 | 2.3 | 1.1 | 5.2 |
| Rasio Cepat | 5.0 | 7.0 | 0.8 | 0.5 | 3.8 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $21M | $-19M | $-31M | $-25M | $-23M |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 140 pengaju · $188.2M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 27 (-4 vs Kuartal sebelumnya) | 17 (-3 vs Kuartal sebelumnya) | 40 (+6 vs Kuartal sebelumnya) | 30 (-8 vs Kuartal sebelumnya) | -56K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | $41.551.898 | 3.300.389 | 22,08% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $15.375.500 | 1.221.247 | 8,17% | Saham |
| VANGUARD GROUP INC | $14.879.573 | 1.473.225 | 7,91% | Saham |
| Propel Bio Management, LLC | $10.971.681 | 871.460 | 5,83% | Saham |
| STATE STREET CORP | $8.552.135 | 679.280 | 4,55% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $7.923.535 | 629.139 | 4,21% | Saham |
| ALGERT GLOBAL LLC | $7.311.114 | 580.708 | 3,89% | Saham |
| MILLENNIUM MANAGEMENT LLC | $7.130.611 | 566.371 | 3,79% | Saham |
| Divisadero Street Capital Management, LP | $6.292.432 | 499.796 | 3,34% | Saham |
| ExodusPoint Capital Management, LP | $4.530.940 | 359.884 | 2,41% | Saham |
| Private Wealth Advisors, LLC | $3.913.765 | 310.863 | 2,08% | Saham |
| Simplify Asset Management Inc. | $3.333.454 | 264.770 | 1,77% | Saham |
| BlackRock, Inc. | $3.180.738 | 252.640 | 1,69% | Saham |
| ADAR1 Capital Management, LLC | $2.825.007 | 224.385 | 1,50% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $2.570.450 | 204.166 | 1,37% | Saham |
| KENNEDY CAPITAL MANAGEMENT LLC | $2.570.160 | 204.143 | 1,37% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.435.510 | 193.448 | 1,29% | Saham |
| Ikarian Capital, LLC | $2.337.548 | 185.667 | 1,24% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $2.290.159 | 181.903 | 1,22% | Saham |
| CIBC WORLD MARKET INC. | $2.054.789 | 163.208 | 1,09% | Saham |
| Caption Management, LLC | $1.894.795 | 150.500 | 1,01% | Opsi jual |
| GOLDMAN SACHS GROUP INC | $1.885.353 | 149.750 | 1,00% | Saham |
| Lane Generational LLC | $1.884.257 | 149.663 | 1,00% | Saham |
| HSBC HOLDINGS PLC | $1.705.848 | 135.600 | 0,91% | Saham |
| Man Group plc | $1.617.752 | 128.495 | 0,86% | Saham |
| Cubist Systematic Strategies, LLC | $1.562.514 | 145.350 | 0,83% | Saham |
| Diametric Capital, LP | $1.546.568 | 122.841 | 0,82% | Saham |
| MORGAN STANLEY | $1.366.506 | 108.539 | 0,73% | Saham |
| BARCLAYS PLC | $1.354.243 | 107.565 | 0,72% | Saham |
| Caption Management, LLC | $1.259.000 | 100.000 | 0,67% | Opsi beli |
| Capital Advisors Wealth Management, LLC | $1.170.870 | 93.000 | 0,62% | Saham |
| Jefferies Financial Group Inc. | $1.057.308 | 83.980 | 0,56% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.050.824 | 83.465 | 0,56% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.022.308 | 81.200 | 0,54% | Opsi beli |
| Stonepine Capital Management, LLC | $1.000.000 | 100.000 | 0,53% | Opsi beli |
| Caption Management, LLC | $978.243 | 77.700 | 0,52% | Saham |
| FOX RUN MANAGEMENT, L.L.C. | $776.526 | 61.678 | 0,41% | Saham |
| Quantbot Technologies LP | $749.860 | 59.560 | 0,40% | Saham |
| D. E. Shaw & Co., Inc. | $728.885 | 57.894 | 0,39% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $725.864 | 57.654 | 0,39% | Saham |
| Pale Fire Capital SE | $504.670 | 40.085 | 0,27% | Saham |
| BANK OF AMERICA CORP /DE/ | $493.931 | 39.232 | 0,26% | Saham |
| WOLVERINE TRADING, LLC | $479.600 | 44.000 | 0,25% | Opsi beli |
| RHUMBLINE ADVISERS | $458.822 | 36.444 | 0,24% | Saham |
| ALPS ADVISORS INC | $441.154 | 35.040 | 0,23% | Saham |
| EntryPoint Capital, LLC | $437.641 | 34.761 | 0,23% | Saham |
| SEI INVESTMENTS CO | $394.936 | 31.369 | 0,21% | Saham |
| AMERICAN CENTURY COMPANIES INC | $378.380 | 30.054 | 0,20% | Saham |
| Balyasny Asset Management L.P. | $358.412 | 28.468 | 0,19% | Saham |
| Leonteq Securities AG | $348.730 | 27.699 | 0,19% | Saham |
| CITADEL ADVISORS LLC | $334.894 | 26.600 | 0,18% | Opsi beli |
| BOOTHBAY FUND MANAGEMENT, LLC | $319.484 | 25.376 | 0,17% | Saham |
| Xcelsior Advisor Partners LLC | $318.527 | 25.300 | 0,17% | Saham |
| Palisades Investment Partners, LLC | $293.007 | 23.273 | 0,16% | Saham |
| WOLVERINE TRADING, LLC | $269.666 | 24.740 | 0,14% | Saham |
| ALLIANCEBERNSTEIN L.P. | $239.424 | 25.800 | 0,13% | Saham |
| MetLife Investment Management, LLC | $235.043 | 18.669 | 0,12% | Saham |
| Bank of New York Mellon Corp | $234.942 | 18.661 | 0,12% | Saham |
| WealthPlan Investment Management, LLC | $219.607 | 17.443 | 0,12% | Saham |
| NOMURA HOLDINGS INC | $210.530 | 16.722 | 0,11% | Saham |
| WOLVERINE TRADING, LLC | $209.280 | 19.200 | 0,11% | Opsi jual |
| CITADEL ADVISORS LLC | $202.699 | 16.100 | 0,11% | Opsi jual |
| CITADEL ADVISORS LLC | $189.391 | 15.043 | 0,10% | Saham |
| SkyOak Wealth, LLC | $188.850 | 15.000 | 0,10% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $188.850 | 15.000 | 0,10% | Opsi jual |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $166.729 | 13.243 | 0,09% | Saham |
| TUDOR INVESTMENT CORP ET AL | $151.609 | 12.042 | 0,08% | Saham |
| LANARK FINANCIAL, INC. | $150.500 | 11.954 | 0,08% | Saham |
| CITIGROUP INC | $146.485 | 11.635 | 0,08% | Saham |
| Invesco Ltd. | $143.790 | 11.421 | 0,08% | Saham |
| MERCER GLOBAL ADVISORS INC /ADV | $140.744 | 11.179 | 0,07% | Saham |
| Nuveen, LLC | $138.754 | 11.021 | 0,07% | Saham |
| Vanguard Global Advisers, LLC | $133.869 | 10.633 | 0,07% | Saham |
| Schonfeld Strategic Advisors LLC | $131.136 | 10.416 | 0,07% | Saham |
| LPL Financial LLC | $128.859 | 10.235 | 0,07% | Saham |
| TWO SIGMA INVESTMENTS, LP | $126.580 | 10.054 | 0,07% | Saham |
| Police & Firemen's Retirement System of New Jersey | $110.729 | 8.795 | 0,06% | Saham |
| SHERBROOKE PARK ADVISERS LLC | $109.918 | 10.883 | 0,06% | Saham |
| Hunting Hill Global Capital, LLC | $104.716 | 11.284 | 0,06% | Saham |
| MARSHALL WACE, LLP | $84.177 | 6.686 | 0,04% | Saham |
| FMR LLC | $69.144 | 5.492 | 0,04% | Saham |
| Private Wealth Advisors, LLC | $62.950 | 5.000 | 0,03% | Opsi beli |
| NEW YORK STATE COMMON RETIREMENT FUND | $60.432 | 4.800 | 0,03% | Saham |
| OSAIC HOLDINGS, INC. | $60.254 | 4.786 | 0,03% | Saham |
| Point72 (DIFC) Ltd | $53.931 | 5.017 | 0,03% | Saham |
| NORTHERN TRUST CORP | $53.797 | 4.273 | 0,03% | Saham |
| Persistent Asset Partners Ltd | $52.954 | 4.206 | 0,03% | Saham |
| Arax Advisory Partners | $51.884 | 4.121 | 0,03% | Saham |
| IFP Advisors, Inc | $51.657 | 4.103 | 0,03% | Saham |
| Integrated Wealth Concepts LLC | $48.145 | 3.824 | 0,03% | Saham |
| Ameritas Investment Partners, Inc. | $38.714 | 3.075 | 0,02% | Saham |
| Legal & General Group Plc | $34.534 | 2.743 | 0,02% | Saham |
| CWM, LLC | $29.343 | 3.162 | 0,02% | Saham |
| Creative Planning | $17.777 | 1.412 | 0,01% | Saham |
| Tripletail Wealth Management, LLC | $16.632 | 1.260 | 0,01% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $14.950 | 1.611 | 0,01% | Saham |
| AlphaQuest LLC | $14.473 | 1.433 | 0,01% | Saham |
| Tower Research Capital LLC (TRC) | $13.711 | 1.089 | 0,01% | Saham |
| Activest Wealth Management | $12.590 | 1.000 | 0,01% | Saham |
| Geneos Wealth Management Inc. | $11.621 | 923 | 0,01% | Saham |
Orang dalam perusahaan 46 orang dalam · 11 pejabat · 16 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Jennifer K. Simpson | President and CEO | 8 Mei 2020 C | 25.021 | 0 | 0 | $0 |
| Barbra Keck | Chief Financial Officer, Secretary | 8 Mei 2020 C | 12.851 | 0 | 0 | $0 |
| Paul M Feinstein | Chief Financial Officer | 30 Nov. 2007 A | 3.375 | 0 | 0 | $0 |
| John Purpura | Chief Operating Officer | 13 Okt. 2023 P | 41.526 | 0 | 0 | $0 |
| HERSCHKOWITZ SAMUEL /FA/ | Chief Operating Officer | 29 Mei 2007 P | 160.375 | 0 | 0 | $0 |
| Vojo Vukovic | Chief Medical Officer | 12 Des. 2023 P | 100.000 | 0 | 0 | $0 |
| Sandra Pennell | SVP of Finance, PFO and PAO | 17 Nov. 2023 P | 30.000 | 0 | 0 | $0 |
| David L. Hoffman | General Counsel, Chief Compliance Officer and Secretary | 16 Nov. 2023 P | 40.000 | 0 | 0 | $0 |
| Kevin Muir | Vice President Commercial Operations | 12 Juni 2023 A | — | 0 | 0 | $0 |
| Johnny John | Senior Vice President Clinical Development and Medical Affairs | 12 Juni 2023 A | — | 0 | 0 | $0 |
| Christine Padula | Interim Principal Accounting Officer | 1 Sep. 2021 A | — | 0 | 0 | $0 |
| John Richard Sylvester | Direktur | 21 Agu 2023 P | 10.550 | 0 | 0 | $0 |
| Aharon Gil | Direktur | 12 Juni 2023 A | 404.000 | 0 | 0 | $0 |
| Steven A J Salamon | Direktur | 12 Juni 2023 A | 440.100 | 0 | 0 | $0 |
| Roger G Stoll PHD | Direktur | 12 Juni 2023 A | 9.309 | 0 | 0 | $0 |
| Rosalind Advisors, Inc. | Direktur | 19 April 2022 P | 433.100 | 0 | 0 | $0 |
| Marco Taglietti | Direktur | 8 Mei 2020 C | 6.000 | 0 | 0 | $0 |
| William Dodge Rueckert | Direktur | 8 Mei 2020 C | 6.014 | 0 | 0 | $0 |
| Simon Pedder | Direktur | 1 Feb. 2019 A | — | 0 | 0 | $0 |
| Laura A Philips | Direktur | 23 Juli 2015 P | 205.299 | 0 | 0 | $0 |
| Harold S Koplewicz | Direktur | 10 Juni 2015 A | 45.052 | 0 | 0 | $0 |
| Dennis Langer | Direktur | 10 Juni 2015 A | 20.000 | 0 | 0 | $0 |
| Jonathan Lewis | Direktur | 30 Juni 2008 A | 10.000 | 0 | 0 | $0 |
| Mark Corigliano | Direktur | 16 April 2007 M | 198.176 | 0 | 0 | $0 |
| Daniel Isdaner | Direktur | 16 April 2007 M | 253.668 | 0 | 0 | $0 |
| Elizabeth Czerepak | — | 13 Mei 2026 A | — | 0 | 0 | $0 |
| Gerard J Michel | — | 2 Maret 2026 P | 342.034 | 2 | 0 | $198.447 |
| Laura Brege | — | 7 Juli 2014 A | 11.678 | 0 | 0 | $0 |
| Tasos Konidaris | — | 7 Juli 2014 A | 11.678 | 0 | 0 | $0 |
| Gabriel Leung | — | 7 Juli 2014 A | 21.485 | 0 | 0 | $0 |
| Douglas G Watson | — | 7 Juli 2014 A | 136.664 | 0 | 0 | $0 |
| Graham G Miao | — | 14 Nov. 2013 A | 54.000 | 0 | 0 | $0 |
| Peter J Graham | — | 14 Nov. 2013 A | 15.000 | 0 | 0 | $0 |
| William M Appling | — | 15 Juli 2013 A | — | 0 | 0 | $0 |
| Krishna Kandarpa | — | 11 Maret 2013 A | 159.000 | 0 | 0 | $0 |
| Harold Mapes | — | 11 Maret 2013 A | 17.000 | 0 | 0 | $0 |
| Eamonn P Hobbs | — | 11 Maret 2013 A | 162.000 | 0 | 0 | $0 |
| Agustin V Gago | — | 11 Maret 2013 A | 80.944 | 0 | 0 | $0 |
| Robert Ladd | — | 15 Juni 2012 A | 69.534 | 0 | 0 | $0 |
| David Mcdonald | — | 10 Maret 2011 A | 47.706 | 0 | 0 | $0 |
| Pamela Reilly Contag | — | 1 Des. 2010 A | 8.507 | 0 | 0 | $0 |
| Richard Taney | — | 10 Des. 2009 A | 211.485 | 0 | 0 | $0 |
| Jason Andrew Rifkin | — | 12 Okt. 2009 A | — | 0 | 0 | $0 |
| KOLY M S /FA/ | — | 26 Jan. 2007 X | 775.360 | 0 | 0 | $0 |
| Victor Nevins | — | 12 Okt. 2006 M | 180.007 | 0 | 0 | $0 |
| VENKOL TRUST | — | 10 Nov. 2004 J | 892.649 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 17 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc., SALAMON STEVEN A J, Aharon Gil, Rosalind Master Fund L.P., Rosalind Opportunities Fund I L.P. ×15 pengajuan | 10 Feb. 2026 | 9,90% | Amandemen | — | SEC |
| Orang pelapor yang tidak diungkapkan | 16 Des. 2022 | — | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 27 Juli 2022 | — | Pengajuan awal | Investasi pasif | SEC |
| Laddcap Value Partners LP S.S. or, Laddcap Value Associates LLC S.S. or, Laddcap Value Advisors LLC S.S. or, Robert Ladd S.S. or ×2 pengajuan | 2 Agu 2010 | — | Pengajuan awal | — | SEC |
| Robert Ladd | 18 Okt. 2006 | — | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 28 Juli 2006 | — | Pengajuan awal | Kampanye dewan | SEC |
| Orang pelapor yang tidak diungkapkan | 11 Juli 2006 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan | 14 Juni 2006 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan | 8 Juni 2006 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan | 24 Mei 2006 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan | 28 April 2006 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan | 10 Jan. 2006 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan | 6 Jan. 2006 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan | 14 Des. 2005 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan | 10 Nov. 2005 | — | Pengajuan awal | Kampanye dewan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 22 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,24% | 35.814 NS | 31 Mei 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 35.321 NS | 31 Mei 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 13.080 NS | 30 April 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 22.609 NS | 31 Mei 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 1.420 NS | 31 Mei 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1.111 NS | 31 Mei 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1.122 NS | 31 Mei 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.638 NS | 31 Mei 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 28 NS | 31 Mei 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 19.222 NS | 30 April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 Juli 2026 | Harian |
| ITOT · iShares Trust | — | — | 22 Juli 2026 | Harian |
| IWN · iShares Trust | — | — | 17 Agu 2026 | Harian |
| IWO · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IWM · iShares Trust | — | — | 18 Agu 2026 | Harian |
| IWC · iShares Trust | — | — | 18 Agu 2026 | Harian |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13 Juli 2026 | Harian |